Is it technically possible? Or do I need to put them in two rapid mode flowcells?
Thanks in advance.
Thanks in advance.
-
-
As long as the read type (single/Paired) and base length is the same, it doesn't matter what sample type is in any given lane.
The only time it matters is in the processing what you align it to-genome or transcriptome. -
Yeah. That's what I thought. But a BGI staff told me that's not possible. Can it be due to different library sizes?Comment
-
It would be a problem to combine them into one lane as different sizes as they would not cluster equivalently, but separate lanes should be fine.Comment
-
Are the sequencing primers for the two libraries the same?Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.comComment
-
Thank you for your reply. Two of them are exome and the other two are rna-seq. I presume these two sets are prepared differently but they should be at least be able to fit in two lanes. Let me call them and check again...Originally posted by kwaraska View PostComment
-
Since there are two lanes per Rapid Run Mode flow cell, you may can try to load each type of library into each flow cell lane independently.
http://www.illumina.com/products/tru...ading_kit.ilmnComment
-
I called BGI again. They said it is actually feasible but they haven't had any experience with the Truseq Duo Loading Kit yet, so that's why the rep answered that way.
I consider my problem as solved. Thanks everyone for contributing.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment